Park Avenue Securities LLC grew its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 31.4% during the ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

The sellers never planned on owning the 30.7-acre property in Lyme, but bought it after a boat deal fell through. Now it’s ...

Poor mental health was increasingly prevalent from 2011 to 2022, with inequities discernible by age, sex, and racial and ...

Morgan Stanley has recently raised Gilead Sciences Inc (GILD) stock rating, as announced on January 10, 2025, according to Finviz. Earlier, on December 10, 2024, BofA Securities had resumed the stock ...

Situated in Foster City, California, Gilead Sciences, Inc. (GILD) is a top biopharmaceutical company specializing in the ...

Mount Gilead picked up a win at Danville on Wednesday by a 68-44 score. In the KMAC contest, the Indians jumped out to an 18-10 lead in the first quarter and held a 32-21 lead at the break. They would ...

Cardington picked up a win over visiting Danville on Wednesday by a 44-27 score. The Lady Pirates trailed 6-4 after the opening period, but bounced back to take a 16-11 lead into the intermission. The ...

We recently published a list of 15 Best NASDAQ Dividend Stocks To Buy. In this article, we are going to take a look at where ...

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

Gilead Sciences Inc. and the federal government settled a patent-infringement case in which the US sought $1 billion from the ...

With incoming president Donald Trump threatening a trade war with China, experts told BioSpace that the new administration ...